Andrew Tsai
Andrew Tsai is an Equity Research Analyst at Jefferies LLC, specializing in the Thrifts & Mortgage Finance sector since joining the firm in 2017. He holds a BS in Business Administration and Finance from Boston University (2017), is a CFA charterholder, and has been recognized by Institutional Investor magazine in his sector.
Claims from Andrew Tsai
Andrew Tsai"Expect the vaccine for melanoma to enter the market in 2027."Aug 19, 2026
Controversy:Will FDA Approve a Skin Cancer Vaccine by 2028?